Natera, Inc.·4

Jan 29, 8:35 PM ET

Moshkevich Solomon 4

4 · Natera, Inc. · Filed Jan 29, 2026

Research Summary

AI-generated summary of this filing

Updated

Natera (NTRA) President Moshkevich Sells Shares

What Happened
Moshkevich Solomon, President, Clinical Diagnostics at Natera, sold a total of 2,213 shares in two open-market transactions to satisfy tax-withholding obligations tied to vested restricted stock units (RSUs). On 2026-01-27 he sold 1,013 shares at $240.53 each for $243,658, and on 2026-01-28 he sold 1,200 shares at $237.66 each for $285,195 — total proceeds ≈ $528,853. These were sales (not purchases) and appear to be routine tax-related dispositions rather than a market-timing buy signal.

Key Details

  • Transaction dates and prices: 2026-01-27 — 1,013 shares @ $240.53 ($243,658); 2026-01-28 — 1,200 shares @ $237.66 ($285,195).
  • Total shares sold: 2,213; total proceeds ≈ $528,853.
  • Shares owned after transaction: Not stated in the provided filing excerpt.
  • Footnotes: Sales were effected to satisfy tax withholding on vested RSUs and made pursuant to written instructions intended to meet the affirmative-defense conditions of Rule 10b5-1(c). RSU grants referenced dated Jan 26, 2024 (F1) and Jan 27, 2023 (F2).
  • Filing timeliness: Form filed 2026-01-29; transactions on 2026-01-27 and 2026-01-28 — filing appears timely (within the usual 2-business-day Form 4 window).

Context
Sales to cover tax withholding on vested RSUs are common and typically considered routine executive administrative activity rather than an expression of bearish sentiment. Because these were tax-withholding sales executed under written instructions (10b5-1), they are less informative about the insider’s view of the company’s future stock performance.

Insider Transaction Report

Form 4
Period: 2026-01-27
Moshkevich Solomon
PRESIDENT, CLINICALDIAGNOSTICS
Transactions
  • Sale

    Common Stock

    [F1]
    2026-01-27$240.53/sh1,013$243,658143,686 total
  • Sale

    Common Stock

    [F2]
    2026-01-28$237.66/sh1,200$285,195142,486 total
Footnotes (2)
  • [F1]The sale of shares was effected in order to satisfy tax withholding and remittance obligations in connection with the vesting of RSUs and made pursuant to a written instruction that is intended to satisfy the affirmative defense conditions of Rule 10b5-1(c) under the Exchange Act contained in the Reporting Person's Stock Unit Agreement granted on January 26, 2024.
  • [F2]The sale of shares was effected in order to satisfy tax withholding and remittance obligations in connection with the vesting of RSUs and made pursuant to a written instruction that is intended to satisfy the affirmative defense conditions of Rule 10b5-1(c) under the Exchange Act contained in the Reporting Person's Stock Unit Agreement granted on January 27, 2023.
Signature
/s/ Tami Chen, Attorney-in-Fact|2026-01-29

Documents

1 file
  • 4
    form4-01292026_080103.xmlPrimary